This week, we have conversations with Robert Bunn, founder and president of Ultrasound AI; Laura MacNeill, CEO of the Charcot Marie Tooth Research Foundation; and Iris Örhn, investment advisor at Business Region Göteborg.

03:00 Ultrasound AI

30:19 Business Region Gothenburg

39:35 CMTRF

Business Region Gothenburg

Business Region Gothenburg (BRG) is the regional development agency for western Sweden, tasked with driving growth and innovation across key sectors, including life sciences. Its work spans business support, investment promotion, and cluster development.

Gothenburg has more than 600 life science companies with around 11,000 employees, creating a strong ecosystem for biotech, medtech, and pharma. This is reinforced by BRG’s efforts to attract global investors.

The recent NLS Days event, held in Gothenburg for the first time, highlighted the city’s growing influence. It featured the launch of SwedenBIO’s updated pipeline report, which tracks more than 500 active drug development projects across the country.

BRG focuses on infrastructure and innovation platforms such as GoCo Health Innovation City, aiming to strengthen the city’s role in precision medicine, digital health, and advanced therapies. These efforts reflect a long-term strategy to ensure the region remains globally competitive in life sciences.

Ultrasound AI

Ultrasound AI is a US technology company specialising in artificial intelligence solutions for ultrasound diagnostics, with a focus on improving accuracy in pregnancy-related diagnostics. Its technology is designed to predict gestational age and identify risks such as preterm birth with precision, reducing uncertainty in care for premature babies.

By analysing image data alone, the platform aims to support clinicians in making faster, more reliable decisions at the point of care.

Ultrasound AI recently expanded its portfolio, securing additional patents that cover predictive algorithms for obstetric and cardiovascular applications.

These developments build on earlier work in gestational age estimation and preterm birth prediction, areas where AI-driven tools are gaining traction in clinical practice. The company’s technology integrates into existing ultrasound systems, making adoption practical for hospitals and clinics.

As demand for point-of-care diagnostics rises, Ultrasound AI’s approach reflects a broader shift toward data-driven healthcare.

Charcot-Marie-Tooth Research Foundation (CMTRF)

The Charcot-Marie-Tooth Research Foundation (CMTRF) is a non-profit organisation dedicated to accelerating the development of treatments for Charcot-Marie-Tooth disease, a group of inherited neuropathies affecting peripheral nerves.

CMTRF focuses on funding research that moves promising therapies from the laboratory into clinical trials, bridging the gap between discovery and delivery.

It has recently advanced several projects aimed at addressing different genetic subtypes of CMT. These include preclinical studies on gene therapy and small-molecule approaches, as well as partnerships with biotech firms to support early-stage drug development.

The foundation prioritises collaboration with academic researchers and industry partners to maximise impact and shorten timelines for therapeutic breakthroughs.

To get in touch with guest suggestions, or to sponsor or advertise on the podcast, please email [email protected]